Further, OAS was identified as a COVID-19 risk locus in association studies suggesting that the splice-site variant at this locus may reduce the enzymatic activity of OAS-1, influencing COVID-19 outcomes [72,73,74,75,76]. This evidence concerns the gene SMOC1 and COVID-19.